Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DCPH

Deciphera Pharmaceuticals (DCPH) Stock Price, News & Analysis

Deciphera Pharmaceuticals logo

About Deciphera Pharmaceuticals Stock (NASDAQ:DCPH)

Advanced Chart

Key Stats

Today's Range
$25.59
$25.59
50-Day Range
$25.55
$25.59
52-Week Range
$9.90
$25.61
Volume
600 shs
Average Volume
1.29 million shs
Market Capitalization
$2.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DCPH Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

DCPH Stock Analysis - Frequently Asked Questions

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) posted its quarterly earnings data on Tuesday, February, 6th. The company reported ($0.54) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.04. Deciphera Pharmaceuticals's revenue was up 32.9% compared to the same quarter last year.
Read the conference call transcript
.

Deciphera Pharmaceuticals (DCPH) raised $101 million in an initial public offering on Thursday, September 28th 2017. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan and Piper Jaffray served as the underwriters for the IPO and JMP Securities and Nomura were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Deciphera Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
2/06/2024
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DCPH
CIK
1654151
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$194.94 million
Net Margins
-108.86%
Pretax Margin
-108.62%
Return on Equity
-52.42%
Return on Assets
-40.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.19
Quick Ratio
3.94

Sales & Book Value

Annual Sales
$174.91 million
Price / Sales
12.65
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.38 per share
Price / Book
5.84

Miscellaneous

Outstanding Shares
86,476,000
Free Float
82,438,000
Market Cap
$2.21 billion
Optionable
Optionable
Beta
0.19
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:DCPH) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners